The Future of Peptides: Myths, Markets, and Medical Breakthroughs
GETTIN SAVVY - Health, Wealth and BeautyShow Notes
Summary This episode covers the latest in biotech, market trends, and space innovation, featuring expert insights on peptides, new drug approvals, and SpaceX's upcoming IPO. Stay informed on cutting-edge health treatments, market strategies, and space tech developments.
Chapters 00:00 Tech Troubles and Market Outlook 00:39 FDA Approves Eli Lilly's Oral GLP-1 Medication 01:06 Introduction to Zurf and K-Beauty Trends 01:44 Understanding Peptides: Myths and Realities 02:38 Popular Peptides and Their Uses 04:05 Peptides Approved for Specific Indications 05:08 Common Peptides in Beauty and Fitness 06:08 Joe Rogan and the Peptide Recovery Trend 07:07 The Wild West of Peptide Market 08:30 Safety and Regulation of Peptides 10:22 Peptides and Cancer Risks 11:17 Stem Cell Treatments Abroad 12:11 Copper Peptides for Skin and Hair 13:42 Market Volatility and Investment Strategies 15:52 Oil Prices, Geopolitics, and Market Impact 17:31 Energy Stocks and Long-term Investment 20:26 Market Reactions to Tech and Telecom Stocks 33:32 Eli Lilly's Oral GLP-1: A Game Changer 36:04 Potential of SpaceX's IPO and Valuation 43:12 SpaceX's AI Data Centers in Space 45:07 Elon Musk and SpaceX's Future Visions 46:52 The Big Picture: Space, Waste, and Innovation
Host descriptions:
Catherine Murray, a business newscaster and former Wall Street professional at Goldman, William Blair and Deutsche bank. Dr. Melissa Hershberg, a medical practitioner with a specialized interest in preventive health, weight loss and aesthetic medicine.
Disclaimer: for entertainment purposes only, please do your own research, your own homework and consult with a financial advisor for investment discussions. In addition to consulting with your Family Doctor, Physician, GP or other health care providers before making any health and beauty decisions.
If you would like to join our email list, please reach out to [email protected] and let us know.
More from GETTIN SAVVY - Health, Wealth and Beauty
GETTIN SAVVY: In Health, Wealth and Beauty Episode 61
GETTIN SAVVY: In Health, Wealth and Beauty Episode 60
GETTIN SAVVY: In Health, Wealth and Beauty Episode 59 Show Summary: In this conversation, Melissa shares her busy life balancing family, sports, and work. They discuss her experiences in tennis and pickleball, as well as her approach to investing for her children. The discussion shifts to the bond market, exploring recent trends and the implications of rising interest rates. They also touch on stock investments, particularly in technology, and the importance of understanding market dynamics. Finally, they delve into a new vision solution that Melissa is considering. In this conversation, we also delve into various topics including Warren Buffett's investment strategies, the impact of global events on energy prices, Moderna's breakthrough in cancer treatment, postpartum psychosis, and the importance of understanding drug interactions. They explore how these themes interconnect with current market trends and healthcare advancements, providing insights into investment decisions and health management. $MRNA Chapters: 00:00 Juggling Family and Sports 02:58 Investing in the Future 05:46 Understanding Bond Markets 11:51 Market Trends and Stock Investments 18:05 The Impact of Interest Rates 21:07 Exploring New Solutions for Vision 22:56 Buffett's Investment Strategies and Portfolio Insights 27:39 Impact of Global Events on Energy Prices 27:56 Moderna's Breakthrough in Cancer Treatment 39:50 Postpartum Psychosis and Its Implications 43:59 Drug Interactions and Health Tips
Summary: This episode moves between two major themes: the science of beauty and the state of the markets. Melissa discusses hair loss, skin health, and GLP-1 medications as emerging tools in beauty and dermatology, while Catherine covers earnings, the Fed, AI spending, and major stocks like Google, Amazon, SpaceX, and Ralph Lauren.
Summary: In this episode, we explore recent medical studies, market trends, and innovative health tests, providing insights into how these developments impact our health and investments.